Merrimack Pharmaceuticals Inc (MACK.OQ)
21 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|64||2017||Chairman of the Board|
|54||2017||President, Chief Executive Officer, Director|
|50||2017||Chief Financial Officer,Principal Financial Officer, Principal Accounting Officer, Treasurer|
|2017||Head of Human Resources|
- French pharma group Ipsen sees more asset purchases, U.S. growth
- BRIEF-Merrimack Pharmaceuticals Files For Mixed Shelf Of Upto $150 Mln
- BRIEF-Merrimack Announces Appointment Of George Demetri, M.D., To Board Of Directors
- BRIEF-Merrimack reports Q3 loss per share from continuing operations $0.40
- BRIEF-Merrimack receives orphan drug designation for MM-121 for the treatment of type of lung cancer